drugset / Trial / NCT00482664

The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.

NCT00482664 ↗

Phase 2 Completed 84 enrolled Pfizer
RandomizedCrossoverQuadruple-blindTreatment

Summary

CP-866,087 is a non-hormonal compound, acting on the central nervous system, which has been shown in animal models to restore sexual function.

Timeline

Start
2007-07
Primary completion
2008-09
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject CP-866,087 Small molecule 1 mg Oral
Subject CP-866,087 Small molecule 3 mg Oral
Subject CP-866,087 Small molecule 10 mg Oral